Live Chats

Scheduled Live Chats
All scheduled chat sessions with our stem cell experts were recorded and transcripts are now available for review and download.

LIVE CHAT: Mouse ESC/iPSC culture
Mark Kennedy and Soojung Shin
Our experts have tried different mouse ESC/iPSC culture systems, from feeder-dependent to feeder-free, from using serum-based media to 2i and a2i media. Additionally, they have tested a variety of our products for mouse ESC/iPSC applications. Find out what they would recommend for your experiment.

LIVE CHAT: Stem cell characterization and analysis
Don Paul Kovarcik and Uma Lakshmipathy
Characterizing and analyzing cells may be one of the most important steps in stem cell culture. Talk about your techniques and hear our expert opinions about different approaches to creating a complete characterization profile for your cells.

LIVE CHAT: Reprogramming
Uma Lakshmipathy and Chad MacArthur
Find out how our experts have evaluated different reprogramming methodologies and which ones they recommend for your cell type.

LIVE CHAT: Gene editing
Jason Carte and Erik Willems
Ask our experts about which gene editing tools work best for different cell lines and how to improve editing outcomes, or engage in a discussion about how gene editing in stem cells may change the future of modern medicine.

LIVE CHAT: Neural cell culture systems
Navjot Kaur and David Kuninger
Discuss the challenges associated with neural cell culture systems and how our latest product improvements and solutions can help.

LIVE CHAT: Transfection
James Kehler and Donna Trollinger
Ask our experts about the latest in our transfection portfolio including superior transfection efficiency in the most difficult stem cell assays.

LIVE CHAT: PSC culture
Rhonda Newman and Lauren Sangenario
Many different PSC culture media are available and range from feeder-dependent to feeder-free, and from many animal-derived components to more xeno-free formulations. Our experts have tried them all. Learn how they compare and recommend different media for your applications.

LIVE CHAT: Clinical research
Kasey Kime and Sandy Kuligowski
In need of practical advice on what to consider when selecting media and reagents that can support your transition from research to clinical trials and beyond? Ask our knowledgeable cell therapy experts and regulatory team about manufacturing quality standards, quality control testing, regulatory documentation and support that is typically requested by our cell therapy customers as they transition their research to the clinic. 

NOV 8 - 9 2017
5th annual 24 Hours of Stem Cells™ virtual event
27 78 19664

Stay on the leading edge of stem cell research

There’s still time to check out the 5th annual Gibco™ 24 Hours of Stem Cells™ virtual event, the largest virtual stem cell event around the world.

During the on-demand period, you can:

  • Access leading scientific presentations
  • Get free career advice like how to optimize your LinkedIn profile and the power of an elevator pitch
  • Sharpen your stem cell skills with virtual training and certifications
  • Get a free sample* for attending

Experience all of this before the virtual conference doors close on February 9, 2018. Register today.

Already registered? Log into the virtual environment on the right >>

 

What attendees liked about last year's event Explore the virtual event

 


 

If you have additional questions, please contact Chelsie Fritz at chelsie.fritz@thermofisher.com.

 

 

 

*No purchase necessary. This promotion is available only to life science professionals 21 years or older in the US (excluding Puerto Rico) and Canada who currently use human pluripotent stem cells in their research, complete a prequalification call with a Thermo Fisher Scientific sales representative, and plan to use the sample within 4 weeks. Sample requests must be received by December 31, 2017, or until sample supplies are depleted, whichever comes first. Limit one free sample per customer. The sample includes one StemFlex Medium kit (450 mL basal medium, 50 mL supplement): Cat. No. A3349401. Cannot be combined with other discounts or promotions. Offer void where prohibited, licensed or restricted by federal, state, provincial, or local laws or regulation or agency/institutional policy. Other restrictions may apply.
*No purchase necessary. This promotion is available only to life science professionals 21 years or older in the US and Canada. Sample requests must be received by December 31, 2018 or until sample supplies are depleted, whichever comes first. The sample is the B-27 Plus Neuronal Culture System (10 mL supplement and M 500 mL medium): Cat. No. A3653401. Limit one free sample per customer. Cannot be combined with other discounts or promotion. Offer void where prohibited, licensed or restricted by federal, state, provincial, or local laws or regulation or agency/institutional policy. Other restrictions may apply. B-27 is a trademark of the Board of Trustees of Southern Illinois University.


Speakers:
  • Senior Global Cell Culture Specialist, Thermo Fisher Scientific
  • Senior Scientist, Amgen
  • Assistant Research Fellow, Institute of Molecular Biology, Academia Sinica
  • Head of the Stem Cell Unit, University Medical Center Göttingen
  • Senior R&D Manager, Cell Biology, Thermo Fisher Scientific
  • Co-Head, LUMC hiPSC Core Facility, Dept. of Anatomy & Embryology Leiden, University Medical Center
  • Postdoctoral Researcher, Hubrecht Institute for Developmental Biology and Stem Cell Research
  • Senior Manager, Thermo Fisher Scientific
  • Research Associate, Center of Regenerative Medicine in Barcelona
  • Graduate Student, University of North Carolina at Charlotte
  • Assistant Professor, Weizmann Institute of Science
  • Senior Process Development Scientist, Cell and Gene Therapy Catapult
  • Development Engineer / Scientist II, CCRM
  • Senior Staff Scientist, Thermo Fisher Scientific
  • Director of Scientific Alliances, Thermo Fisher Scientific
  • Assistant Professor, Indiana University School of Medicine
  • Associate Staff Scientist, Bioprocessing Technology Institute of Singapore
  • Associate Professor, Commonwealth Industrial and Scientific Research Organisation (CSIRO)
  • Staff Scientist, Thermo Fisher Scientific
  • Assistant Professor, University of Minnesota
  • INSERM Director, iSTEM and President, French Stem Cell Society
  • Communications Director, California Institute for Regenerative Medicine
  • Director, Max Planck Institute for Molecular Genetics
  • Director, R&D, Cell Biology/Transfection at Thermo Fisher Scientific
  • Chair of Anatomy and Embryology and Professor of Developmental Biology, Leiden University Medical Center
  • Staff Scientist, Thermo Fisher Scientific
  • Independent Team Leader, Max Delbrueck Center for Molecular Medicine (MDC)
  • Head of Research, D'Or Institute for Research and Education and Professor of Biomedical Sciences, Federal University of Rio de Janeiro
  • Research Associate, Center for Regenerative Medicine in Barcelona
  • Global Marketing Development Manager, Cell Biology, Thermo Fisher Scientific
  • Chief Scientific Officer (CSO), Braingineering Technologies SARL
  • Director of Therapeutics, Organovo
  • Special Sales Account Manager, Mary Ann Liebert, Inc.
  • CEO and Co-Founder, EpiBone
  • Independent Fellow, IMCB, A*STAR and Adjunct Assistant Professor at SBS and LKCMedicine, NTU, and NUS Medicine
  • Staff Scientist, Thermo Fisher Scientific
  • Field Application Scientist (FAS), Thermo Fisher Scientific

Show Resources
Agenda
Click below each speaker's photo to watch their Webcast
Speakers

  • Mary Kay Bates
    Senior Global Cell Culture Specialist, Thermo Fisher Scientific
    Biography
      Mary Kay Bates is a Senior Global Cell Culture Specialist with Thermo Fisher Scientific, where she provides cell culture expertise to colleagues and customers. Her knowledge is based on twenty years of experience in academic and industrial cell and molecular biology labs, focusing on cancer and gene therapy, authoring several publications. Mary Kay holds an M.S. in microbiology from the University of Wisconsin-Madison, and has presented seminars at institutes around the world.
    • Stuart Chambers
      Senior Scientist, Amgen
      Biography
        Stuart Chambers received his Ph.D. from Baylor College of Medicine in the lab of Margaret A Goodell in studying hematopoietic stem cell biology and gene therapy. His postdoctoral work was conducted in the lab of Lorenz Studer identifying methods to neuralize pluripotent stem cells for the purposes of creating neurons for use in cell therapy and induced pluripotent stem cell disease modeling. His cell therapy work was continued as a Scientist when he joined start-up company Neurona Therapeutics. He now works at Amgen as a Senior Scientist in Discovery Research within the Genome Analysis Unit and is tasked with using pluripotent stem cell derived cell fates for target identification, human disease modeling, and drug development.
      • Jun-An Chen
        Assistant Research Fellow, Institute of Molecular Biology, Academia Sinica
        Biography
          The focus of research in my laboratory is to elucidate how neurons establish individual identity in the developing nervous system and why only specific neuron subtypes are vulnerable in the neurodegenerative diseases. We tackle these questions via studying non-coding RNAs and their roles during motor neuron generation and degeneration. My lab employs motor neurons generated from mouse and human embryonic (ES) and induced pluripotent (iPS) stem cells, as well as mouse animal models to investigate motor neuron development and disease. We have developed and generated a series of stem cells and animal models to study functions of microRNA and lncRNA by "gain-of-function" and "loss-od-function" approaches. Besides elucidating the basic molecular mechanisms underlying specification of neuronal diversity during CNS development, I apply the stem cell system to study motor neuron diseases. In particular, I am engaged in the establishment and study of patient specific iPS cell based models of Spinal Muscular Atrophy (SMA), Amyotrophic Lateral Sclerosis (ALS). iPS cell derived motor neurons are used in my lab to perform deep sequencing from healthy and ALS motor neurons and to functionally characterize non-coding RNA pathology in motor neuron. I am also a core member of Neuroscience Program and RNA program in Academia Sinica, which provides strong and solid consortium to give advices and exchange the ideas for our projects. In summary, I have multidisciplinary approaches, from in vitro stem cells to in vivo mouse models, to study motor neuron development and degeneration.
        • Lukas Cyganek
          Head of the Stem Cell Unit, University Medical Center Göttingen
          Biography
            Lukas Cyganek is head of the Stem Cell Unit at the University Medical Center Göttingen (http://stemcellunit.de). The SCU offers support within the scope of generation, cultivation and characterization of patient-specific induced pluripotent stem cells (iPSCs), its genome editing as well as its in vitro differentiation into patient-specific cardiomyocytes. The SCU further offers their expertise in the analysis of iPSC-derived cardiomyocytes and engineered heart muscles on molecular and functional level for detailed phenotyping. Apart from the laboratory services, the SCU acts as biobank for patient-specific iPSCs and iPSC derivatives (http://dzhk.de/ressourcen/stammzellregister/). During his PhD at the European Neuroscience Institute Göttingen, Lukas Cyganek focused on the neurogenesis of the somatosensory system. In 2013, he joined the stem cell lab of Prof. Kaomei Guan in the cardiology at the University Medical Center Göttingen as a postdoctoral researcher, before he became head of the SCU in 2015. His recent research focusses on the generation of patient-specific as well as engineered iPSCs of and their applications in disease modelling of cardiovascular diseases, drug screening and tissue engineering.
          • Matthew Dallas
            Senior R&D Manager, Cell Biology, Thermo Fisher Scientific
            Biography
              Matt is currently a Senior Manager in Cell Biology Research and Development at Thermo Fisher Scientific. He obtained his Ph.D. in Chemical and Biomolecular Engineering from the Whiting School of Engineering at Johns Hopkins University, training that included a fellowship within the Johns Hopkins Institute for NanoBioTechnology, a multi-disciplinary institution with efforts spanning basic biological science, clinical science, and public health. Matt joined the Gibco R&D team in 2012 and has led development programs spanning oncology, primary human tissue culture, and stem cell biology. His current team is responsible for new product and process development in basal cell culture media, fetal bovine and other animal sera, and recombinant proteins.
            • Christian Freund
              Co-Head, LUMC hiPSC Core Facility, Dept. of Anatomy & Embryology Leiden, University Medical Center
              Biography
                Christian Freund received his PhD at the Max Delbrück Centre for Molecular Medicine in Berlin, Germany, studying the role of transcription factor NF-kB in cardiac hypertrophy in mice. In 2006 he joined the lab of Christine Mummery at the Hubrecht Institute in Utrecht, The Netherlands. He initially worked on the differentiation of human embryonic stem cells into cardiomyocytes and showed that insulin had adverse effects on early specification into the mesoderm lineage. After having moved with the Mummery group to the Leiden University Medical Centre (LUMC) he started working on human cellular reprogramming by exogenous transcription factors. Since 2010 he has been co-heading the LUMC hiPSC core facility which up to date generated human induced pluripotent cells from more than 125 tissue samples for LUMC researchers and external investigators
              • Helmuth Gehart
                Postdoctoral Researcher, Hubrecht Institute for Developmental Biology and Stem Cell Research
                Biography
                  Helmuth Gehart received his PhD from ETH Zurich (Zurich, Switzerland) in 2013. During his PhD training with Prof. Romeo Ricci, Helmuth studied the mechanisms behind Type II Diabetes and the complex cellular checkpoints that maintain balance to prevent disease. Thereafter, Helmuth aimed to combine his knowledge of signaling and metabolism with the fascinating field of stem cell biology. Thus, he joined the group of Prof. Hans Clevers at the Hubrecht Institute (Utrecht, Netherlands). There he investigates adult tissue stem cells of the liver and their use in clinical research and regenerative medicine.
                • Sarah Gibson
                  Senior Manager, Thermo Fisher Scientific
                  Biography
                    Sarah is a Senior Manager in talent acquisition at Thermo Fisher Scientific, leading recruitment delivery for Genetic Sciences and Clinical Next-Generation Sequencing. Sarah has over 18 years of recruiting and human resources experience including many years of management experience. Currently, she manages a full life cycle recruiting team while championing employment branding campaigns, fostering a customer-oriented culture of collaboration, striving for excellence and building meaningful relationships. She is focused on attracting, identifying and welcoming talent whose groundbreaking discoveries and innovations enable our customers to make the world healthier, cleaner and safer. Prior to this role, Sarah was a Recruiting Manager with Korn Ferry Healthcare Sector RPO business working at Stanford Hospitals & Clinics located in Palo Alto, CA. Prior to this role, Sarah spent 12 years in consulting and management with Accenture, where she focused on leading Talent Acquisition efforts for the Information Technology and Outsourcing practice. Sarah holds a Bachelor of Science, from California State University Chico. She is active in her San Francisco community volunteering for philanthropic organizations and local charities.
                  • Alessandra Giorgetti
                    Research Associate, Center of Regenerative Medicine in Barcelona
                    Biography
                      Dr. Giorgetti holds a Bachelor of Biology (1998) and PhD in Molecular Medicine from the University of Milan, Italy. She has a long-standing interest in hematopoietic stem cells, which started in her PhD thesis. She continued her studies in Dr. Rafii´s Lab at the Weill Cornell Medical College in New York. In 2008 she joined Center of Regenerative Medicine of Barcelona (CMRB). Her work contributed to the molecular understanding of nuclear reprogramming (Cell Stem Cell 2009; Nature Protocols 2010; Nature 2011, Stem Cells 2011, PNAS 2012, Nature Commun 2013). In 2012, she joined Inbiomed as Head of the Laboratory of Hematopoiesis and Blood Disorders. In 2013, she relocated to the Josep Carreras Leukaemia Research Institute where she contributed to develop new strategies for the in vitro generation of blood cells (Stem Cell Reports 2016; Exp Hematol 2017; Stem Cells 2017). Recently she relocated to the CMR[B] where she has just established herself as Team Leader.
                    • Donna Goodenow
                      Graduate Student, University of North Carolina at Charlotte
                      Biography
                        I was born, raised and am currently living in Charlotte, North Carolina. I received my Bachelors of Science in Biology from Queens University of Charlotte. Now I am a third year Biology PhD student at the University of North Carolina at Charlotte (UNCC). Before beginning graduate school, I worked at Carolinas Medical Center in the General Surgery Research Department studying hemorrhagic shock and reperfusion injury in a rat model. At UNCC, I study the effects of dietary bioflavonoids on mouse embryonic stem cells to determine if these flavonoids cause improper DNA repair leading to chromosomal translocations and cancer.
                      • Jacob Hanna
                        Assistant Professor, Weizmann Institute of Science
                        Biography
                          Dr. Hanna earned a B.Sc. in Medical Sciences (2001, summa cum laude), and a PhD/MD in clinical medicine (2007, summa cum laude), all from the Hebrew University of Jerusalem, Israel. For more than four years, he conducted postdoctoral research with Prof. Rudolf Jaenisch at the Whitehead Institute for Biomedical. In his recently established lab at the Weizmann Institute, Dr. Hanna combines diverse experimentation methods with computational biology to explore topics in embryonic stem cell biology, early embryonic development and the modeling of human diseases. Projects include deciphering the mechanisms by which IPS and germ cells are produced, characterizing unique naïve human pluripotent stem cells and various stages in early human development. In addition to helping elucidate the molecular basis of cell reprogramming, this research offers the promise of creating powerful research models for infertility, cancer, degenerative and autoimmune diseases such as type 1 diabetes. His numerous honors and fellowships include a Novartis Fellowship by the Helen Hay Whitney Foundation (2007), a Genzyme-Whitehead Fellowship for outstanding postdoctoral fellows (2009), the TR35 award by MIT review magazine for young innovators (2010), a European Research Council early career development award (2011), the Rappaport prize in biomedical research (2013), the Krill prize by the Wolf Foundation for outstanding research achievements (2013), featured among "40 under 40" innovative scientists by Cell press (2014) and recently became an EMBO member (2017).
                        • Jahid Hasan
                          Senior Process Development Scientist, Cell and Gene Therapy Catapult
                          Biography
                            Jahid is a Senior Process Development Scientist at the Cell and Gene Therapy Catapult where he has been working for the last 4 years on various upstream and downstream development projects including the Cell Plasticity platform programme. He holds a doctorate degree from the University of Leeds where he developed a method for decellularising porcine meniscus with bone blocks for use as a meniscal replacement therapy. Jahid completed the Biochemical Engineering undergraduate programme at University College London gaining an MEng degree during which he undertook a year of work at Lonza's Cell Culture Process Development team in Slough-UK. Here, he assessed medium formulation and stability on CHO cell culture.
                          • Calley Hirsch
                            Development Engineer / Scientist II, CCRM
                            Biography
                              Calley Hirsch has been a Development Engineer / Scientist II at CCRM in Toronto for 8 months, where she specializes in upstream lentiviral production and gene delivery technologies. Prior to working at CCRM, Calley was a postdoctoral fellow at the Lunenfeld-Tanenbaum Research Institute in Toronto and MD Anderson Cancer Center in Houston working on pluripotent stem cells and somatic cell reprogramming. Calley received her PhD from the University of Saskatchewan.
                            • Navjot Kaur, PhD
                              Senior Staff Scientist, Thermo Fisher Scientific
                              Biography
                                Navjot Kaur is a Senior Staff Scientist at Thermo Fisher Scientific in the Cell Biology business based in Frederick, MD. She is part of a team focusing on research, development and commercialization of next generation tools and reagents for Neurobiology, stem cell culture and differentiation. She has served as an R&D lead for launch of over 8 new products in the market spanning Neurobiology, cryopreservation, and stem cell differentiation areas. Navjot has developed and utilized a range of research tools including media formulation optimization, verification & validation process, development of standardized QC assays, technology transfer, manufacturing protocols, experimental design and statistical analyses. Prior to starting at Thermo Fisher Scientific in 2007 as Staff Scientist, she joined University at Buffalo, NY as a Postdoctoral Fellow and published more than 20 research articles in peer-reviewed journals in the fields of Neurobiology, Cell Signaling, and Protein Biochemistry.
                              • James Kehler VMD, PhD
                                Director of Scientific Alliances, Thermo Fisher Scientific
                                Biography
                                  James Kehler VMD, PhD is a comparative stem cell biologist who thrives on developing productive collaborations to translate scientific discoveries into transformative products. He trained at the University of Pennsylvania, where he received his VMD in 2002, and PhD in Cell and Molecular Biology in 2004. James has worked as a visiting researcher at the National Institutes of Health for over 10 years, where he and his collaborators at NEI, NCI, NINDS, NIDDK and NIAAA developed animal and stem cell-based models of human diseases. He has run workshops on reprogramming and gene-editing both at the NIH, as well as internationally. James has worked and consulted for several stem cell companies from product development and management to directing custom reprogramming and gene-editing services. In 2016, James joined MTI-GlobalStem, now part of Thermo Fisher Scientific, as Director of Scientific Alliances, to foster collaborative research projects with academic, biotech and pharmaceutical partners.
                                • Karl Koehler
                                  Assistant Professor, Indiana University School of Medicine
                                  Biography
                                    Karl Koehler, PhD is an Assistant Professor of Otolaryngology-Head and Neck Surgery at Indiana University School of Medicine. He joined the faculty after completing his PhD degree in Medical Neuroscience in 2014 under the mentorship of Dr. Eri Hashino. Dr. Koehler began his career studying how embryonic and induced pluripotent stem cells could be used to produce neurons to treat hearing loss patients. His early work, published in Nature and Nature Protocols, detailed a novel culture system for growing mini inner ear organs, known as inner ear organoids, from mouse pluripotent stem cells. He then spearheaded an effort to decode the signaling mechanisms required to coax human pluripotent stem cells to become inner ear organoids. This work was recently published in Nature Biotechnology in June 2017. His research now focuses on using the organoid culture system as a platform to develop regenerative therapies for the inner ear and various craniofacial tissues. His work is funded by grants from the National Institute of Health and the Indiana Clinical and Translational Research Institute.
                                  • Alan Lam
                                    Associate Staff Scientist, Bioprocessing Technology Institute of Singapore
                                    Biography
                                      Dr Alan Lam graduated with a PhD (Biochemistry) from Chinese University of Hong Kong. He is currently the associate staff scientist in the Stem Cell Bioprocessing Group at the Bioprocessing Technology Institute, A*STAR, Singapore. His research interest focuses on developing scalable platforms using microcarriers for adult and pluripotent stem cell derivation, expansion and differentiation. A list of his publications can be found at https://www.a-star.edu.sg/bti/Research/Research-Groups/Stem-Cells.aspx
                                    • Andrew Laslett
                                      Associate Professor, Commonwealth Industrial and Scientific Research Organisation (CSIRO)
                                      Biography
                                        Dr. Andrew Laslett is a Research Team Leader with the CSIRO Manufacturing business unit, where he leads a human pluripotent stem cell biology research team; He also holds an Adjunct Associate Professor position with the Australian Regenerative Medicine Institute at Monash University and is an Honorary Senior Fellow with the School of BioSciences at Melbourne University. Since 2001, Andrew and his laboratory have focused on elucidating the complex biology of human embryonic stem cells (hESC), examined methods for the differentiation of hESC to renal progenitor cells and more recently begun comparing hESC to reprogrammed human cells termed induced pluripotent stem (iPS) cells. His laboratory is currently focused on exploiting the basic biology of these cell types to create novel cell lines and tools that enhance human pluripotent cell research translation within CSIRO, Australia and internationally. Prior to his current role with CSIRO, Andrew was a Senior Scientist and Group Leader of the Human Embryonic Stem Cell Technology Laboratory at the Australian Stem Cell Centre (ASCC) following Senior Research Fellow appointments in the Laboratory of Embryonic Stem Cell Biology and the Centre for Reproduction and Development, Monash Institute of Medical Research, Monash University. He obtained his BSc (Hons) and PhD (1996) from Monash University prior to undertaking postdoctoral positions in both Hong Kong and Philadelphia, USA.
                                      • Xiquan Liang
                                        Staff Scientist, Thermo Fisher Scientific
                                        Biography
                                          Xiquan Liang graduated from City College of New York in 1999. He joined Thermo Fisher Scientific as a staff scientist in 2004. Since then he has led development of product development leadership in protein analysis, including High Molecular Weight MS standard, SILAC for protein identification and quantification, and Dynabeads-TiO2 for phosphopeptide enrichment. He is now engaged in product development in Synthetic Biology, including Bluegrass, GeneArt seamless DNA assembly tools, site-directed mutagenesis , and CRISPR-mediated mammalian cell engineering in the Life Sciences Solutions Group of Thermo Fisher Scientific in Carlsbad, CA. He is focused on developing tools for the entire Synthetic Biology workflow, specifically DNA cloning, Gene Synthesis and Assembly, and Molecular and Cell Engineering.
                                        • Alessandro Magli
                                          Assistant Professor, University of Minnesota
                                          Biography
                                            Dr. Alessandro Magli has worked in the skeletal muscle field for over 10 years. After completing his college studies at the University of Modena and Reggio Emilia (Italy), Dr. Magli earned his doctoral degree in the same institution by studying the molecular regulation of skeletal muscle differentiation. He later moved to the University of Minnesota where he conducted his post-doctoral training in the laboratory of Rita Perlingeiro. During this time, he investigated the mechanisms of cell fate choice during development, with a special focus on the mesodermal lineage derivatives. In particular, these studies recently resulted in the identification of markers for the purification of myogenic progenitors from differentiating human pluripotent stem cells, a finding that may enable the application of these ES-derived myogenic cells in cell therapy of muscle diseases. Dr. Magli is author of multiple scientific papers and, among other achievements, he was recipient of the Minnesota Regenerative Medicine educational award in 2015
                                          • Cécile Martinat
                                            INSERM Director, iSTEM and President, French Stem Cell Society
                                            Biography
                                              Research projects developed by my group, that is implanted in the institute ISTEM, is to better understand physiological mechanisms implicated in the development of neuromuscular diseases and subsequently to develop new therapeutic strategies. We have three main domains of research: i). improve the protocols of differentiation to convert efficiently and reliably cell types of interest, i.e. motoneurons and muscle cells; ii). To improve our knowledge on the communication between motoneurons and muscle cells by developing new cellular systems iii). apply these different tools to neuromuscular diseases with the aim to decipher physiopathological mechanisms and to identify new pharmacological strategies. My group is mainly interested in two neuromusuclar diseases: myotonic dystrophy type 1 and spinal muscular atrophy. I recently took the head of the INSERM Unit located in ISTEM, institute dedicated to the use of human pluripotent stem cells to develop new therapeutic strategies for monogenic diseases. Two main of applications are developed in ISTEM: cell therapy and drug screening. More recently, I have been elected president of the French Society for Stem Cell Research (FSSCR, www.fsscr.fr). The main objective of this society, launched in January 2017, is to underpin and federate short and long-term efforts to ensure the place of France as a leader in the domain of stem cell research.
                                            • Kevin McCormack
                                              Communications Director, California Institute for Regenerative Medicine
                                              Biography
                                                Kevin McCormack is the Communications Director at CIRM, the state's stem cell agency. He considers himself to be the official translator for the agency, working to turn complex language about equally complex science into everyday English that anyone can understand. Before joining the agency he spent more than 20 years working as a journalist, most of that in TV news in San Francisco.
                                              • Alexander Meissner
                                                Director, Max Planck Institute for Molecular Genetics
                                                Biography
                                                  Alexander Meissner studied Medical Biotechnology at the Technical University Berlin before starting his PhD studies with Rudolf Jaenisch at the Whitehead Institute/MIT in 2002. He completed his PhD in 2006 and spent the next year and a half working with Rudolf Jaenisch and Eric Lander before starting his own lab as an assistant professor in the Department of Stem Cell and Regenerative Biology at Harvard University and as an associate member of the Broad Institute in 2008. He was promoted to associate professor in 2012 and full professor with tenure in 2015. In 2016 he has been appointed as Director and Head of the Department of Genome regulation at the Max Planck Institute for Molecular Genetics in secondary employment and changed it to his principal employment in 2017.
                                                • Xavier de Mollerat du Jeu
                                                  Director, R&D, Cell Biology/Transfection at Thermo Fisher Scientific
                                                  Biography
                                                    Xavier de Mollerat du Jeu, Ph.D. is a Director of R&D transfection group at Thermo Fisher Scientific, working on creating and improving new nucleic acids delivery for both research and therapeutic applications. Xavier identified new DNA delivery approaches for hard to transfect cell lines and primary/stem cells and he is the inventor of Lipofectamine® 3000. Xavier's team is also focusing on new delivery solutions for CRISPR delivery, new scalable lentiviral production systems, mechanical delivery approaches for primary T cells and in vivo delivery of RNAi/mRNA for research and therapeutic application. He studied molecular biology and plant physiology at the University of Montpellier II in France, and received his Ph.D. in human genetics in 2003 from Clemson University in South Carolina. His thesis work involved identifying the gene(s) responsible for Split Hand/Split Foot Malformation 3 (SHFM 3). His post-doctoral fellowship research was in the laboratory of Dr. Michael G. Rosenfeld at UCSD, where he studied the roles of microRNAs in pituitary gland development. He joined Thermo Fisher in 2005.
                                                  • Christine Mummery
                                                    Chair of Anatomy and Embryology and Professor of Developmental Biology, Leiden University Medical Center
                                                    Biography
                                                      Christine Mummery is Chair of Anatomy and Embryology and Professor of Developmental Biology at Leiden University Medical Center. Her research concerns cardiovascular development and disease models based on human pluripotent stem cells. Immediate interests are on developing biophysical techniques for characterization and functional analysis of cardiovascular cells from hPSC. In 2015 she became guest professor at the Technical University of Twente to develop organ-on-chip models. Dr. Mummery is a member of the Royal Netherlands Academy of Science, on the board of the Netherlands Medical Research Council and holds a European Research Council Advanced Grant to study cardiac development and disease in humans based on stem cell models. She wrote a lay-guide on stem cells "Stem Cell: Scientific Facts and Fiction" (Elsevier 2014) and is Editor-in-Chief of Stem Cell Reports, the journal of the International Society of Stem Cell Research. She is also on the editorial boards of Cell Stem Cell, Cardiovascular Research and Stem Cells.
                                                    • Suman Pradhan
                                                      Staff Scientist, Thermo Fisher Scientific
                                                      Biography
                                                        Dr. Pradhan joined Thermo Fisher scientific in 2016 and is currently working on next generation tools and technologies development with the goal of providing assays and methods for molecular characterization of stem cells and T cells utilizing methylation platform, array-based whole genome and transcriptomic profiling and TaqMan qPCR assays. He earned his Ph.D. in Molecular Biophysics from University of Calcutta, India, investigating the structural and functional consequences of binding of putative anti-cancer small molecules to chromatin in the context of transcription and disease. After graduating Dr. Pradhan moved to United States and did two postdocs -- a brief one at UC San Diego followed by a second postdoc at UC Los Angeles. He made a few seminal contributions in unraveling the mechanism of eukaryotic gene expression and silencing leveraging sophisticated biochemistry and extensive next generation sequencing approaches.
                                                      • Alessandro Prigione
                                                        Independent Team Leader, Max Delbrueck Center for Molecular Medicine (MDC)
                                                        Biography
                                                          Dr. Prigione is an Independent Team Leader at the Max Delbrueck Center for Molecular Medicine (MDC) in Berlin. His group was established in 2015 with the generous support of a junior investigator grant from the German Ministry of Education and Research (BMBF). Dr. Prigione received a M.D. from the University of Milan in 2002 and a Ph.D. from the San Raffaele Institute of Milan in 2008. During his Ph.D., Dr. Prigione worked on neurological diseases at the University of Milan-Bicocca and on mitochondrial disorders at the University of California in Davis, USA. As postdoctoral scientist at the Max Planck Institute for Molecular Genetics in Berlin, Dr. Prigione described for the first time the reconfiguration occurring to mitochondria during the reprogramming of human fibroblasts to iPSCs. The focus of the Prigione lab is now the application of iPSCs in modeling and treatment discovery of neurological diseases with mitochondrial impairment. His latest work was published in Cell Stem Cell in January 2017 and demonstrated the use of iPSC-derived neural cells for drug discovery of neurological disorders caused by mitochondrial DNA mutations.
                                                        • Stevens Rehen
                                                          Head of Research, D'Or Institute for Research and Education and Professor of Biomedical Sciences, Federal University of Rio de Janeiro
                                                          Biography
                                                            Stevens Rehen received his Bachelor's degree, Master's degree, and Ph.D. at the Federal University of Rio de Janerio in Brazil. He later completed postdoctoral training at the University of California San Diego and The Scripps Research Institute. Over the past five years, Stevens has published over 76 peer-reviewed publications. Currently, Stevens is a Full Professor at the Federal University of Rio de Janerio. Additionally, he is the Head of Research at D'Or Institute for Research and Education (IDOR) and Regional Committee Member of the Pew Latin American Program in the Biomedical Sciences.
                                                          • Meritxell Rovira
                                                            Research Associate, Center for Regenerative Medicine in Barcelona
                                                            Biography
                                                              Meritxell Rovira holds a Bachelor in Biology (2001) from University of Barcelona and a PhD in Health and Life Science (2007) from University Pompeu Fabra. After her PhD she moved to USA in 2008 for her postdoctoral training at Johns Hopkins/School of Medicine to work in Steve D Leach and Mike Parsons laboratories, where she acquired expertise in adult pancreatic progenitors in mouse and zebrafish models. She came back to Barcelona in 2011 as a Marie Curie postdoctoral fellow at Jorge Ferrer laboratory (IDIBAPS) where she gained expertise in the field of epigenetics. After her postdoctoral training, she joined Núria López-Bigas laboratory at IRB as a research associate to stablish and supervise the experimental part of Núria's lab. She joined the CMR[B] in 2017 after being awarded with a Jovenes Investigadores fellowship from the Spanish Ministry. Meritxell's main research interest is the study of pancreatic progenitors in zebrafish, mouse and human. Embryonic pancreatic multipotent progenitors and adult pancreatic duct cells express common markers in all animal species studied thus far; suggesting that adult duct cells might be exploited to create a pool of β-cell progenitors. Thus my main research interest is to understand the transcriptional and epigenetic changes that occur between embryonic progenitors and adult cells, as well as the influence of the extrinsic signals from the surrounding mesenchymal cells. This knowledge will allow the identification of the molecular mechanisms that restrict the lineage potential of duct cells and could be used to create a model of β-cell regeneration for the treatment of Type 1 Diabetes.
                                                            • Christopher Scanlon
                                                              Global Marketing Development Manager, Cell Biology, Thermo Fisher Scientific
                                                              Biography
                                                                Chris is a Global Marketing Development Manager in Cell Biology Research Sera at Thermo Fisher Scientific. He obtained his Bachelor of Science Business Administration majoring in Marketing from West Virginia University. Also, in 2013 he received an Associate of Applied Science in Nursing from Trocaire College. Chris joined the company back in 2006 as a Senior Marketing Program Manager and is currently based at the Grand Island, NY location which is home to the Gibco manufacturing site. He is responsible for all Gibco Sera marketing and programs that communicate the benefits of our Gibco cell culture products to researchers around the world.
                                                              • Jens Schwamborn
                                                                Chief Scientific Officer (CSO), Braingineering Technologies SARL
                                                                Biography
                                                                  Since 2013 Jens C. Schwamborn, PhD, is head of the Developmental and Cellular Biology group at the Luxembourg Centre for Systems Biomedicine (LCSB) as well as Professor at the University of Luxembourg. Additionally, since 2016 Jens is Chief Scientific Officer of the biotech company Braingineering Technologies. In 2002 Jens obtained is diploma in Biochemistry from the University Witten/Herdecke in Germany and in 2005 his PhD in Biology from the University Muenster in Germany. He worked as a postdoctoral researcher at the Institute for Molecular Biotechnology in Vienna / Austria. The focus of his work over the last years was on Neurobiology, Stem Cell research and Parkinson's disease. In particular he is interested in using human induced pluripotent stem cells for the development of advanced approaches for in vitro disease modeling. Jens published more than 50 papers in peer reviewed journals, holds several patents and severs as reviewer for numerous journals and funding agencies.
                                                                • Benjamin Shepherd
                                                                  Director of Therapeutics, Organovo
                                                                  Biography
                                                                    Dr. Shepherd has more than 17 years of experience in Tissue Engineering and Regenerative Medicine research. Dr. Shepherd's research in vascular biology and microvascular tissue engineering has been focused on the ability to use creative approaches to generate microvascular networks to support the fabrication and surgical implantation of prevascularized neotissues. In addition to these research interests, he has successfully led early-stage research programs in liver biology, oncology and directed differentiation of stem cells within 3D and bioprinted tissues. Prior to joining Organovo, he was an Associate Research Scientist at the Yale School of Medicine, where he also conducted postdoctoral training. In addition to his appointment at Yale, he was a staff perfusionist at the University of Connecticut Health Center. Dr. Shepherd is a board certified clinical perfusionist (C.C.P.), received his Ph.D. in Physiological Sciences from the University of Arizona and a B.S. in Zoology from the University of Washington.
                                                                  • Rebecca Shumbata
                                                                    Special Sales Account Manager, Mary Ann Liebert, Inc.
                                                                    Biography
                                                                      Rebecca Appleby Shumbata received her degree from Connecticut College. Today, Rebecca is a scholarly publishing professional with over 15 years of experience. At Mary Ann Liebert publishers, Rebecca works with organizations to find topics and customize existing content, create new content, or extend planned live content into enduring educational materials that improve branding and generate leads. Before joining Mary Ann Liebert publishers, Rebecca worked with publishers and institutions to improve the dissemination of research at Kudos. Prior to that, Rebecca served as Senior Global Sales Manager for Hosting Platforms at Ingenta, previously Publishing Technology. Rebecca has 8 additional years of publishing experiencing working for publishers, Cell Press, published by Elsevier, and the New England Journal of Medicine, published by the Massachusetts Medical Society. Rebecca is also co-Chair of the Society for Scholarly Publishing Development Committee.
                                                                    • Nina Tandon
                                                                      CEO and Co-Founder, EpiBone
                                                                      Biography
                                                                        Nina Tandon is CEO and co-founder of EpiBone, the world's first company growing living human bones for skeletal reconstruction. She is the co-author of Super Cells: Building with Biology, a book that explores the new frontier of biotech. She is a TED Senior Fellow, Adjunct Professor of Electrical Engineering at the Cooper Union and a former Staff Associate Postdoctoral Researcher in the Laboratory for Stem Cells and Tissue Engineering, Columbia University. She has a Bachelor's in Electrical Engineering from the Cooper Union, a Master's in Bioelectrical Engineering from MIT, a PhD in Biomedical Engineering, and an MBA from Columbia University. Her PhD research focused on studying electrical signaling in the context of tissue engineering, and has worked with cardiac, skin, bone, and neural tissue.
                                                                      • Adrian Teo
                                                                        Independent Fellow, IMCB, A*STAR and Adjunct Assistant Professor at SBS and LKCMedicine, NTU, and NUS Medicine
                                                                        Biography
                                                                          Adrian Teo is an Independent Fellow at IMCB and an Adjunct Assistant Professor at NTU and NUS. He obtained his B.Sc. (1st Class) from NUS and then worked on human pluripotent stem cells (hPSCs) with Ray Dunn, Ph.D., and Alan Colman, Ph.D., at ES Cell International Pte. Ltd. followed by IMB. In April 2008, he joined the laboratory of Ludovic Vallier, Ph.D., at the University of Cambridge to pursue his Ph.D., under the AGS(O) scholarship. Concurrently, he was also an Honorary Cambridge Commonwealth Trust Scholar. He completed his Ph.D. in July 2010 and joined the laboratory of Ray Dunn, Ph.D., at IMB as a postdoctoral fellow before heading to the laboratory of Rohit Kulkarni, M.D. Ph.D., at Joslin Diabetes Center, Harvard Medical School. During his fellowship, he obtained HSCI seed grants and a JDRF fellowship to pursue his research interests in using hPSCs for in vitro disease modelling of diabetes. He currently runs the Stem Cells and Diabetes Laboratory with a major focus on differentiating human pluripotent stem cells (hPSCs) into pancreatic cells and cell types affected in diabetic complications to dissect the pathology of diabetes and its complications
                                                                        • Erik Willems
                                                                          Staff Scientist, Thermo Fisher Scientific
                                                                          Biography
                                                                            Dr. Erik Willems was trained as a stem cell biologist in Brussels, Belgium where he obtained his PhD in 2007, after which he soon relocated to San Diego, California to develop his expertise in the use of pluripotent stem cells in high throughput screening assays for understanding the basic biology and disease of the developing heart in the Sanford Burnham Prebys Medical Discovery Institute. Dr. Willems then pursued his passion for the development of biotechnology tools and applications and joined Thermo Fisher Scientific in Carlsbad, California where he - as a Manager in the Cell Biology Business - currently leads pluripotent stem cell-based customer driven projects and product applications, including characterization, reprogramming, genome editing, differentiation and disease modeling with a focus on drug discovery applications. Now in the stem cell field for over 15 years, Dr. Willems published numerous peer reviewed articles including in high impact journals such as Cell Stem Cell. His key expertise encompasses pluripotent stem cell biology, differentiation, genome editing, high throughput screening and drug discovery.
                                                                          • Ania Wronski
                                                                            Field Application Scientist (FAS), Thermo Fisher Scientific
                                                                            Biography
                                                                              Ania Wronski, PhD, is the CellModels Field Application Scientist (FAS) for the Cell Biology group within Thermo Fisher Scientific. She is passionate about providing solutions for researchers applying Cell Models such as iPSCs to the world of drug discovery. As an FAS, Ania travels the country, supporting the cell biology sales force and helping life science researchers do amazing work. Ania received her PhD in molecular biology and biochemistry from the University of Queensland in Australia and completed a four year postdoctoral study in the lab of Charlotte Kuperwasser at Tufts University.
                                                                            Education

                                                                            What educational opportunities are available on-demand?

                                                                            NEW! Career Development Center
                                                                            This year’s virtual event featured a career development track which provided free career advice from experts in the field, career development resources, and educational opportunities such as virtual training and handbooks.

                                                                            Event certification
                                                                            Participate in select activities throughout the event such as presentations, booths, virtual labs, and more to earn your event certificate and free T-shirt*. Event certification is only available until February 9, 2018.

                                                                            Virtual training labs
                                                                            Test your stem cell knowledge in our virtual, interactive training labs. Topics include pluripotent stem cell culture, transfection and more.

                                                                            Scheduled live chats
                                                                            Access transcripts from the live chat sessions with our R&D experts. See specific topics here.

                                                                             

                                                                            *No purchase necessary. This promotion is available only to qualifying attendees of 24 Hours of Stem Cells who earned an event certification. Qualifying attendees will receive a T-shirt. Qualifying attendees in China will receive a LED table lamp. Free T-shirt or lamp is available to eligible participants who submit a request no later than February 9, 2018 or until gift supplies are depleted, whichever comes first. The estimated value of the T-shirt is $12.00 USD, and the estimated value of the lamp is $15.00 USD. One free gift per person. Life Technologies will fulfill T-shirt size requests whenever possible, but reserves the right to substitute sizes if necessary. Healthcare professionals may not participate in this promotion. Government Officials may not participate in this promotion. The term Government Official includes anyone who acts in an official capacity for or on behalf of a government entity, department, or agency. By registering, you warrant that you are not prohibited by employment, contract, or law from accepting a gift from Life Technologies. Offer void where prohibited, licensed, or restricted by federal, state, provincial, or local laws or regulation or agency/institutional policy. Other restrictions may apply.

                                                                            Help

                                                                            General LabRoots Questions

                                                                            For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
                                                                            Contact us

                                                                            Virtual Events and Webinars

                                                                            Supported Configurations

                                                                            • Operating System Internet Explorer Firefox Chrome Safari
                                                                              Vista IE8+ FF10+ Chrome15+
                                                                              Windows 7 IE8+ FF10+ Chrome15+
                                                                              Windows 8 IE10 FF10+ Chrome15+
                                                                              Mac OS X   FF10+ Chrome15+ Safari5.1+
                                                                            • Cookie settings: session cookies enabled
                                                                            • Browser configuration must have JavaScript enabled
                                                                            • Adobe Flash player 10.2 or later

                                                                            To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                                                                            Internet Connection

                                                                            • A minimum of 100Kbps is recommended for audio-only events
                                                                            • A minimum of 300Kbps is recommended for speaker on-video events

                                                                            Computer Equipment

                                                                            • Screen Resolution: Minimum 1024x768
                                                                            • Video Card: 65,000 colors minimum
                                                                            • Sound card and speakers (or headphones) for hearing webcast in full format
                                                                            • Audio Card: 16-bit minimum
                                                                            • RAM: 512MB of free RAM

                                                                            Firewall Protocol

                                                                            • HTTP on port 80 or HTTPS on port 443
                                                                            • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                                                                            • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                                                                            Work-At-Home Attendees

                                                                            • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                                                                            For A Seamless Experience

                                                                            When using a mobile device, FREE Mobile Apps are available:

                                                                            - For viewing Webinars:

                                                                            - For viewing Virtual Events

                                                                            Attendee Guide

                                                                            • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                                                                            Virtual Event and Webinar Support:

                                                                            Continuing Education (CME/CE) Support

                                                                            Loading Comments...
                                                                            Show Resources